BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Business

  Roche and Gilead Launch COVID-19 Trial to Test One-Two Punch of Actemra and Remdesivir

  “As more information about COVID-19 pneumonia becomes available in these unprecedented times, it is more important than ever to work together to fight this disease,” said Levi Garraway, Roche’s chief medical officer and head of Global Product Development.

  May 28, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Neurotrope and NIH Launch Long-Term Trial of Bryostatin in Alzheimer’s

  The Phase II study will be performed in collaboration with the National Institutes of Health under a $2.7 million grant.

  May 28, 2020

   · 

  2 min read

   · 

  Mark Terry
• 

  Drug Development

  Biopharma Update on the Novel Coronavirus: June 1

  Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 1, 2020.

  May 28, 2020

   · 

  3 min read

   · 

  BioSpace Editorial Staff
• 

  Policy

  Biopharma Update on the Novel Coronavirus: May 28

  Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 28, 2020.

  May 28, 2020

   · 

  6 min read

   · 

  BioSpace Editorial Staff
• 

  How the Pandemic Has Impacted Employee Satisfaction

  Under regular circumstances, the level of employee happiness within a position usually depends on a variety of things. Due to the onset of COVID-19, people have had to reflect on many aspects of their employment.

  May 28, 2020

   · 

  3 min read

   · 

  Porschia Parker-Griffin
• 

  BioCapital

  Research Roundup: Children and COVID-19 and More

  Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

  May 28, 2020

   · 

  5 min read

   · 

  Mark Terry
• 

  Policy

  Recalls Could be Imminent After FDA Discovers Carcinogens in Popular Diabetes Drug

  The tests revealed that some metformin products contained the presence of N-nitrosodimethylamine (NDMA) levels above the acceptable daily intake levels established by the regulatory agency.

  May 28, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Amount of Nasal Protein Receptors Possibly Linked with COVID-19 Susceptibility

  A protein called ACE2 is intimately involved in how SARS-CoV-2, the virus that causes COVID-19, infects the body.

  May 28, 2020

   · 

  4 min read

   · 

  Mark Terry
• 

  Drug Development

  Startup ViralClear Drives Antiviral into Phase II for COVID-19 Following Significant Preclinical Results

  ViralClear Chief Executive Officer Nick Spring told BioSpace that the preclinical work is “telling a very good story.”

  May 28, 2020

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  GSK Pledges One Billion Doses of Adjuvant Technology for COVID-19 Vaccine Candidates

  The company is expanding its manufacturing efforts in Europe, Canada, the United Kingdom and the United States in order to meet this goal.

  May 28, 2020

   · 

  2 min read

   · 

  Alex Keown